REGULATED PRESS RELEASE

from LISI (EPA:FII)

2026 Half yearly results

HALF-YEARLY RESULTS 30th June 2026

External Public

The LISI Group announces a significant improvement in its results for the 1st half of 2026, ahead of schedule

  • Revenue growth driven by strong activity across all segments of the aerospace market,
  • Improved profitability ahead of schedule: current operating margin of 11.3%, supported by significant productivity gains and the increasing value of the product portfolio in both divisions,
  • Half-year EBIT exceeded €100 million for the first time,
  • FCF remains positive, with capacity investments and inventory levels tailored to support the acceleration of business at the LISI AEROSPACE division and thereby secure customer deliveries.
  • 2026 targets confirmed driven by high-stakes projects: improvement for the fourth consecutive fiscal year of key financial indicators, including current operating income, as well as, once again, the generation of a positive Free Cash Flow*.

Paris, July 23, 2026—LISI today announced its results for the 1st half-year ended June 30, 2026. These financial statements were subject to a limited review by the Statutory Auditors and were presented to the Board of Directors at its meeting held today.

Six months ended June 30
Key items in the income statementH1 2026H1 20251Change
Revenue M€942.9891.7+5.7%
EBITDA M€148.3133.1+11.4%
EBIT M€106.286.5+22.8%
Current operating margin %11.3%9.7%+1.6 pts
Reported net income for the period attributable to the company’s equity holders M€62.438.5+62.1%
Diluted earnings per share1.340.83+67.5%
Key items in the cash flow statementH1 2026H1 2025Change
Cash flow from operations M€119.488.8+30.6 €M
Net capital expenditures M€-48.0-52.7-4.7 €M
Operating Free Cash Flow2 M€5.9-14.3+20.2 €M
Key Financial Highlights
H1 202612/31/2025Change
Net financial debt M€265.1233.7+31.4 €M
Net debt-to-equity ratio %23.2%21.4%+1.8 pts

Comments on the Half-Year Performance

Revenue in M€2026202512026 / 2025On a like-for-like basis and at constant exchange rates
1st quarter468.0442.0+5.9%+10.9%
2nd quarter474.9449.7+5.6%+7.0%
6 months ended June 30942.9891.7+5.7%+9.2%

* The consolidated figures for 2025 do not include LISI MEDICAL’s revenue for the first quarter of 2025, which amounted to €44.7 million, or for the second quarter, which amounted to €42.4 million.

Consolidated revenue for the first half of 2026 totaled 942.9 €M, up +5.7% compared to the same period in 2025, and reflects the following factors:

  • an average negative currency impact of -28.2 €M (3.0% of revenue), resulting primarily from the weakening of the average U.S. dollar exchange rate against the euro;
  • a scope-of-consolidation effect of +3.3 €M (0.4% of revenue) related to the acquisition of LISI AUTOMOTIVE Hungary on September 30, 2025;
  • a scope-of-consolidation effect of -5.6 €M (0.6% of revenue) related to the removal of Ankit (India) from the LISI AEROSPACE scope of consolidation on December 31, 2025.

Adjusted for currency and scope changes over the first six months of the year, organic growth remained at a high level of +9.2% of revenue.

EBITDA reached 148.3 €M, an increase of 15.2 €M compared to H1 2025. Both divisions contributed to this result:

  • LISI AEROSPACE: strong volume effect and improved industrial productivity. This improvement stems, on the one hand, from the automation of manufacturing processes, and on the other hand, from training efforts for the many new hires in 2023 and 2024,
  • LISI AUTOMOTIVE: progress in the structural reduction of the break-even point, combined with the continued repositioning of the product portfolio toward higher-value-added products.

The current EBITDA margin reached 15.7% of revenue (14.9% in H1 2025, which had benefited from the lingering effects of inflation on selling prices).

The net effect of provisions and reversals of provisions of +4.3 €M in the first half of 2026 is primarily due to the reclassification of a provision that had no impact on current operating income.

As a result, half-year EBIT exceeded 100 €M for the first time in the Group’s history, reaching 106.2 €M - an increase of 22.8% compared to the first half of 2025 - representing a recurring operating margin of 11.3% versus 9.7% in H1 2025.

Non-recurring operating income and expenses totaled -23.0 €M, compared to -3.4 €M in H1 2025. These primarily reflect costs associated with the transfer of operations from the Puiseux site (France) to other sites within the LISI AUTOMOTIVE division (see the April 23, 2026 press release regarding the first quarter).

The financial result came in at -2.7 €M (-40.0 €M in H1 2025). This is attributable to the following main factors:

  • effects related to the revaluation of foreign-currency debts and receivables and the change in the fair value of hedging instruments, amounting to +3.7 €M compared to -29.1 €M in H1 2025;
  • financial expenses, corresponding to the cost of net long-term debt, of -8.9 €M (-13.1 €M in H1 2025);
  • gains on investments of working capital, amounting to +2.5 €M (+2.2 €M in H1 2025).

The corporate income tax rate was 23.8%, in line with the Group’s historical rates.

Net income amounted to 62.4 €M (representing 6.6% of revenue), compared to 38.5 €M (4.3% of revenue) in H1 2025.

Operating Free Cash Flow was positive at 5.9 €M, driven by an increase in cash flow from operations.

At 119.4 €M, cash flow from operations is up compared to the same period of the prior fiscal year (+30.6 €M) and represents 12.7% of revenue. It covers the full 48.0 €M in funding required for investment programs. These programs are primarily dedicated to advancing strategic initiatives aimed at implementing multi-year industrial programs and developing new products and technologies.

Working capital requirements stand at 84 days of revenue (75 days as of December 31, 2025), with inventories - expressed in terms of days of revenue - on the rise (109 days compared with 99 days as of December 31, 2025). These inventories consist primarily of raw materials and work-in-progress intended to support production increases in the coming months to meet the sharp rise in demand from major customers in the LISI AEROSPACE division.

Taking these factors into account and in line with established objectives, operating Free Cash Flow was positive at 5.9 €M (0.6% of revenue).

Solid financial structure characterized by the Group’s historically low debt level

Net financial debt stood at 265.1 €M in the first half of 2026, including 123.3 €M in debt related to lease agreements (IFRS 16). It represents 23.2% of equity and 1.0x current EBITDA (annualized). It is well below the covenants authorized by the banking partners, which are set at 120% of equity and 3.5x current EBITDA (annualized), respectively.

LISI AEROSPACE (70% of total consolidated revenue)

  • Significant revenue growth driven by strong activity across all segments of the aerospace market and market share gains,
  • Improved manufacturing productivity following the high level of hiring in recent years and the implementation of plans to optimize production flows,
  • Positive operating Free Cash Flow amid a rise in work-in-progress inventory to meet the sharp increase in demand from the division’s major customers.
Analysis of Revenue Trends
Revenue in M€202620252026 / 2025On a like-for-like basis and at constant exchange rates
1st quarter325.1294.4+10.4%+17.6%
2nd quarter338.1306.5+10.3%+13.1%
6 months ended June 30663.2600.8+10.4%+15.8%
Aerospace Market

Global air traffic and cargo volumes performed well during the first half of the year despite the crisis in the Strait of Hormuz.

The global commercial aviation market remains strong, with long-term prospects still favorable, as reflected in the high volume of orders received by major manufacturers. Demand from airlines continues to outpace supply from aircraft manufacturers.

Production rates continue to rise for the Airbus A320 family (currently 66 aircraft per month, with a target of 75 aircraft per month by 2027) as well as for the A350 program. At Boeing, the ramp-up in production of the B737 MAX and B787 has materialized. The strong performance of the helicopter and defense segments, which account for 10% and 15% of the division’s business, respectively, is also helping to support overall demand.

Comments on First-Half Performance

Revenue for the LISI AEROSPACE division reached a record high of 663.2 €M in the first half of 2026, up 10.4% from the already high baseline of the first half of 2025.

With a 23.7% increase, revenue for the “Fasteners” business in the United States during the first half of 2026 posted the strongest growth; it benefited from Boeing’s ramp-up. The “Fasteners” business in Europe and the “Structural Components” business also posted strong growth, up 10.7% and 11.2%, respectively, compared to the first half of 2025.

Adjusted for currency effects and the change in scope resulting from the divestiture of Ankit (India) as of December 31, 2025, the LISI AEROSPACE division’s revenue posted sustained organic growth of +15.8% in the first half of 2026.

Record Results

The division benefited from volume increases, market share gains, initiatives to expand high-value￾added product lines, improved industrial productivity following the initial phase of heavy hiring in previous fiscal years, and the ongoing optimization of production flows.

The current EBITDA margin thus increased by 1.3 points compared to the first half of 2025, reaching 18.4% of revenue. The EBIT totaled 97.3 €M. Operating leverage was particularly strong, driven by improved industrial productivity (revenue: +10.4%, recurring operating income: +30.7%). The recurring operating margin increased by 2.3 points compared to H1 2025 and stood at 14.7% of the division’s revenue.

Operating Free Cash Flow increased compared to the first half of the year (6.6 €M as of June 30, 2026, compared to 1.4 €M as of June 30, 2025), despite an increase in work-in-progress inventory linked to the ramp-up in production.

Capital expenditures totaled 37.1 €M (31.9 €M in 2025), primarily intended to support the ramp-up of production capacity and boost industrial productivity in response to sustained customer demand.

LISI AUTOMOTIVE (30% of total consolidated revenue)

  • Decline in global production among the division’s major customers,
  • Market share gains driven by strong momentum in new product order intake,
  • Temporary effects related to the industrial reorganization following the shutdown of manufacturing operations at the Puiseux-Pontoise site (France).
Analysis of Revenue Trends
Revenue in M€202620252026 / 2025On a like-for-like basis and at constant exchange rates
1st quarter143.0148.3-3.5%-2.6%
2nd quarter136.9143.8-4.8%-6.3%
6 months ended June 30279.9292.1-4.2%-4.4%
Automotive Market

Global light vehicle registrations fell by -3.9% in the first half of 2026 compared to the same period last year. This decline was particularly pronounced in China (-22.7%) and in the NAFTA region (Canada, United States, Mexico) at -2.1%. The European region, meanwhile, posted growth of +6.1%.

Comments on the Half-Year Performance

Revenue for the LISI AUTOMOTIVE division totaled 279.9 €M in the first half of 2026, down -4.2% compared to the same period in 2025.

Adjusted for currency effects and the change in scope resulting from the consolidation of LISI AUTOMOTIVE Hungary in October 2025, the decline was -4.4% in the first half of 2026 and reflects:

  • a 2.5% decline in global production by the division’s automotive manufacturer customers;
  • a resolutely maintained strategy to reposition the product portfolio toward higher-value-added product families, initiated several years ago. This focus is reflected in orders for new products, which remain particularly strong, accounting for 12.2% of revenue for the half-year.

The division continues to expand in promising and profitable segments (braking systems, electromobility, interior trim, and cable channels). It demonstrates agility in adapting its product lines and solid operational execution.

Results

The implementation of the industrial reorganization related to the shutdown and transfer of manufacturing activities from the Puiseux-Pontoise site (France) to other sites within the division is proceeding according to plan but is temporarily leading to increases in inventory.

Nevertheless, the division’s financial indicators show good resilience, thanks in particular to the disciplined pursuit of measures to optimize fixed costs.

The current EBITDA margin thus stood at 10.3% (11.1% in H1 2025), and the operating margin reached 4.2% (4.9% in H1 2025). The EBIT totaled 11.8 €M (14.3 €M in H1 2025).

Operating Free Cash Flow for the period was negative at -2.7 €M (+5.0 €M in H1 2025), primarily impacted by the temporary build-up of inventory associated with the transfer of manufacturing activities from the Puiseux-Pontoise site (France) to other entities within the division.

The division also maintained a steady level of investment over the half-year (10.8 €M) to ensure the continued development of new products and improvements in industrial productivity.

LISI GROUP OUTLOOK AND OBJECTIVES FOR 2026–2027

LISI AEROSPACE

The aerospace market remains particularly favorable across all civil platforms. The helicopter and defense segments are also maintaining their strong momentum. Gaining market share with major strategic customers - notably through the renewal of major contracts in 2025 and 2026 - is further driving this growth. In addition, LISI AEROSPACE’s order backlog for 2026 and 2027 remains very strong. The key focus areas are therefore:

  • the establishment of additional production capacity (the “Fasteners” business) and the improvement of industrial productivity (the “Structural Components” business), in order to meet growing demand;
  • the ability to increase production volumes while maintaining control over the cost structure and inventory levels. The goal is to meet customer needs and ensure the continuity of programs amid persistent, significant pressures across the entire aerospace supply chain.
LISI AUTOMOTIVE

LISI AUTOMOTIVE is continuing the structural initiatives it has been implementing for several years, with two priorities: securing its positioning in new vehicle models and adjusting the fixed-cost structure. These efforts aim to preserve the division’s competitiveness and its ability to rebound in a global automotive market undergoing profound changes in terms of competition, geography, and technology.

Priorities for the second half of the year center on two major areas:

  • advancing the industrial reorganization project underway at the Puiseux-Pontoise site (France). This includes transferring production to other sites within the “Clipped Solutions” business, as well as relocating the sales teams and design office to the LISI AEROSPACE site in Saint-Ouen l’Aumône,
  • finalizing the operational and functional integration of LISI AUTOMOTIVE Hungary in Györ, along with strengthening industrial capacity at the division’s sites in China, Mexico, and Morocco.
LISI Group

The Group reaffirms its ambition to improve its key financial indicators for the fourth consecutive year in 2026 - most notably recurring operating income - and to generate positive operating Free Cash Flow.

The Group’s longer-term cross-functional strategic initiatives - automation, robotization, digitalization, new products, capacity investments, and rationalization of its geographic footprint - will support the expansion of production capacity, the enhancement of the portfolio’s value, and improved productivity. Given their implementation timelines, learning curves, and the need to adapt industrial resources to program development, their rollout could temporarily moderate operational leverage without undermining the strength of the Group’s current trajectory.

Building on solid financial fundamentals, the LISI Group reaffirms its ability to strengthen its global positions in its high-value-added businesses over the long term.

LISI Group Consolidated Income Statement

(in thousands of euros)06/30/202606/30/20251
REVENUE EXCL. TAX942 879891 689
Changes in inventories, finished products and production in progress27 71414 390
Total production970 593906 078
Other income18 28229 308
TOTAL OPERATING REVENUES988 875935 386
Consumed goods(276 424)(266 979)
Other purchases and external expenses(212 594)(207 019)
Taxes and duties(7 679)(7 707)
Employee benefits expense (including temps)(343 838)(320 567)
EBITDA148 340133 114
Depreciation(46 404)(46 501)
Net provisions4 257(155)
CURRENT OPERATING PROFIT (EBIT)106 19386 458
Non-recurring operating income and expenses(23 023)(3 443)
OPERATING PROFIT83 16983 015
Financing expenses and revenue on cash(6 477)(10 820)
Revenue on cash2 6132 289
Financing expenses(9 090)(13 109)
Other financial income and expenses3 739(29 147)
Other financial items20 89212 291
Other interest expenses(17 152)(41 438)
Taxes (including CVAE (Tax on Companies' Added Value))(19 143)(11 136)
RESULTS OF CONTINUING OPERATIONS61 28831 912
Results from discontinued operations6 798
PROFIT (LOSS) FOR THE PERIOD61 28838 710
Attributable as company shareholders' equity62 43738 506
Interest not granting control over the company(1 149)204
EARNINGS PER SHARE (IN €)1,360,84
DILUTED EARNINGS PER SHARE (IN €)1,340,83

SUMMARY OF STATEMENT OF COMPREHENSIVE INCOME

(in thousands of euros)06/30/202606/30/2025
PROFIT (LOSS) FOR THE PERIOD61 28838 710
Elements not recyclable in result
Revaluation of net liabilities (assets) of defined benefit plans (gross element)-1 547-443
Revaluation of net liabilities (assets) of defined benefit plans (tax impact)900
Elements that can subsequently be recycled as a result
Exchange rate differences resulting from foreign operations14 312-46 516
Hedging instruments (gross element)-7012 736
Hedging instruments (tax impact)177-698
TOTAL OTHER PORTIONS OF GLOBAL EARNINGS FOR THE PERIOD, AFTER TAXES12 331-44 921
TOTAL OVERALL INCOME FOR THE PERIOD74 290-6 212
Attributable as company shareholders' equity74 782-6 086
Interest not granting control over the company-491-125

Consolidated balance sheet of the LISI Group

ASSETS
ASSETS (in thousands of euros)06/30/202612/31/2025
NON-CURRENT ASSETS
Goodwill322 622318 031
Other intangible assets24 05424 731
Tangible assets703 020676 426
Non-current financial assets52 98250 852
Deferred tax assets49 20648 067
Other non-current assets
TOTAL NON-CURRENT ASSETS1 151 8841 118 107
CURRENT ASSETS
Inventories517 780460 682
Taxes - Claim on the state16 47312 770
Trade and other receivables292 602241 518
Cash and cash equivalents246 756270 437
TOTAL CURRENT ASSETS1 073 612985 407
Assets held for sale13 498
TOTAL ASSETS2 225 4962 117 012
EQUITY AND LIABILITIES
TOTAL EQUITY AND LIABILITIES (in thousands of euros)06/30/202612/31/2025
30/06/202631/12/2025
SHAREHOLDERS' EQUITY
Capital stock18 61518 615
Treasury shares(19 742)(19 796)
Consolidated reserves1 055 442934 762
Conversion reserves28 83314 521
Other elements of comprehensive income(4 961)(2 981)
Profit (loss) for the period62 437139 724
TOTAL SHAREHOLDERS' EQUITY - GROUP'S SHARE1 140 6191 084 843
Interest not granting control over the company2 5986 175
TOTAL SHAREHOLDERS' EQUITY1 143 2171 091 018
NON-CURRENT LIABILITIES
Non-current provisions63 04671 956
Non-current borrowings350 500395 118
Other non-currents liabilities12 29314 054
Deferred tax liaibilities38 94041 844
TOTAL NON-CURRENT LIABILITIES464 780522 972
CURRENT LIABILITIES
Current provisions27 7065 753
Current borrowings161 307109 040
Trade and other accounts payable414 164359 771
Taxes due14 32224 027
TOTAL CURRENT LIABILITIES617 499498 591
Liabilities directly associated with assets held for sale4 431
TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES2 225 4962 117 012
* Including short-term banking facilities20 38814 682

LISI Group Consolidated Cash Flow Statement

(in thousands of euros)06/30/202606/30/2025
OPERATING ACTIVITIES
NET PROFIT (LOSS)61 28838 710
Elimination of net expenses not affecting cash flows:
- Depreciation, Amortization and non-current financial provisions46 38445 934
- Changes in deferred taxes(4 466)(4 324)
- Incarne on disposals, provisions for liabilities and others15 7958 967
GROSS CASH FLOW MARGIN119 00189 287
Net changes in provisions associated with ongoing operations411(501)
OPERATING CASH FLOW119 41088 787
Income tax expense elimination23 60817 775
Restatement of financial items (interest and exchange)7 20229 720
Effect of changes in inventory(54 561)(42 200)
Effect of changes in accounts receivable and accounts payable2 775(17 025)
NET CASH PROVIDED BY OR USED FOR OPERATIONS BEFORE TAX98 43677 056
Tax paid(37 384)(8 924)
CASH PROVIDED BY OR USED FOR OPERATING ACTIVITIES (A)61 05268 133
INVESTMENT ACTIVITIES
Acquisition of consolidated companies
Acquired cash
Acquisition of tangible and intangible fixed assets(58 610)(53 322)
Acquisition of financial assets(2 003)(5 000)
Change in granted loans and advances(24)
TOTAL CASH USED FOR INVESTMENT ACTIVITIES(60 637)(58 322)
Proceeds from the sale of subsidiaries, net of cash transferred6 415(6 671)
Disposal of consolidated companies
Disposal of tangible and intangible fixed assets10 628619
Disposal of financial assets
TOTAL CASH FROM DISPOSALS17 042(6 053)
CASH PROVIDED BY OR USED FOR INVESTMENT ACTIVITIES (B)(43 594)(64 377)
FINANCING ACTIVITIES
Capital increase
Capital decrease (OPRA)
Dividends paid to Group shareholders(21 305)(17 897)
Dividends paid to minority interests of consolidated companies
TOTAL CASH FROM EQUITY TRANSACTIONS(21 305)(17 897)
New long-term loans40 96641 573
New short-term loans8021 702
Repayment of long-term loans(1 424)640
Repayment of short-term loans(60 618)(59 018)
Net interest expense paid(7 200)(12 183)
TOTAL CASH FROM ON LOANS AND OTHER FINANCIAL LIABILITIES(27 473)(27 287)
CASH PROVIDED BY OR USED FOR FINANCING ACTIVITIES (C)(48 778)(45 184)
Effect of change in foreign exchange rates (D)1 879(12 445)
Effect of adjustments in treasury shares (D)54644
CHANGES IN CASH (A+B+C+D)(29 387)(53 230)
Cash at January 1 (E)255 754152 270
Cash at year-end (A+B+C+D+E)226 36899 040
Cash and cash equivalents246 756255 248
Short-term banking facilities(20 388)(156 208)
CLOSING CASH POSITION226 36899 040

Changes in the LISI Group's Consolidated Equity

(in thousands of euros)Capital stockCapital-linked premiumsTreasury sharesConsolidated reservesConversion reservesOther elements of comprehensive incomeProfit for the period, Group shareGroup's share of shareholders' equityMinority interestsTotal shareholders' equity
SHAREHOLDERS’ EQUITY AT JANUARY 1, 202518 615(20 080)891 75459 635(6 295)56 006999 6336 5671 006 200
Profit (loss) for the period N (a)38 50638 50620438 710
Translation differences (b)(46 171)(46 171)(345)(46 516)
Payments in shares989989989
Restatement of treasury shares689283972972
Revaluation of net liabilities (assets) of defined benefit plans (c)-443-443-443
Appropriation of N-1 earnings56 006(56 006)
Dividends distributed(17 897)(17 897)(17 897)
Restatement of financial instruments (d)2 0222 022162 038
Various(38)(38)(38)
SHAREHOLDERS’ EQUITY AT June 30ST, 202518 615(19 391)931 10413 464(4 716)38 506977 5746 441984 014
including total income and expenses reported for the year (a) + (b) + (c) + (d)0(46 171)1 57938 506(6 086)(125)(6 212)
SHAREHOLDERS’ EQUITY AT JANUARY 1ST, 202618 615(19 796)934 75814 521(2 981)139 7241 084 8436 1751 091 018
Profit (loss) for the period N (a)62 43762 437(1 149)61 288
Translation differences (b)14 31214 31267014 983
Payments in shares2 1072 1072 107
Restatement of treasury shares54262316316
Perimeter variations(3 053)(3 053)
Revaluation of net liabilities (assets) of defined benefit plans (c)-1 456-1 456-1 456
Appropriation of N-1 earnings139 724(139 724)
Dividends distributed(21 305)(21 305)(21 305)
Restatement of financial instruments (d)-511-523-13-523
Various-124-124-31-155
SHAREHOLDERS’ EQUITY AT JUNE 30 202618 615(19 742)1 055 44228 833(4 961)62 4371 140 6192 5981 143 217
including total income and expenses reported for the year (a) + (b) + (c) + (d)14 312-1 96762 43774 782(491)74 290

Notes

  1. In accordance with IFRS 5, the 2025 figures have been restated following the sale of the LISI MEDICAL division on October 31, 2025. Income from discontinued operations is presented on a separate line item in the income statement titled “Income from discontinued operations, net of tax.” The 2025 comparative figures relating to the sale of LISI MEDICAL on October 31, 2025, have been restated to conform to this presentation.
  2. Operating Free Cash Flow: cash flow from operations less net capital expenditures and changes in working capital.
See all LISI news